Silence Therapeutics PLC | Income Statement
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
117.00
15.00
-
770.00
16.00
399
Cost of Goods Sold (COGS) incl. D&A
-
-
182.00
-
433.00
399
Gross Income
-
-
182.00
-
417.00
399
SG&A Expense
8,812.00
11,810.00
9,587.00
12,366.00
13,974.00
20,166
EBIT
8,992.00
12,127.00
9,769.00
11,906.00
14,391.00
20,565
Unusual Expense
80.00
-
-
-
-
-
Non Operating Income/Expense
-
8.00
-
-
10,631.00
-
Interest Expense
-
-
-
-
15.00
-
Pretax Income
9,002.00
11,980.00
9,429.00
10,362.00
3,775.00
20,526
Income Tax
-
892.00
2,784.00
1,922.00
2,157.00
2,115
Consolidated Net Income
9,002.00
11,088.00
6,645.00
8,440.00
1,618.00
18,411
Net Income
9,002.00
11,088.00
6,645.00
8,440.00
1,618.00
18,411
Net Income After Extraordinaries
9,002.00
11,088.00
6,645.00
8,440.00
1,618.00
18,411
Net Income Available to Common
9,002.00
11,088.00
6,645.00
8,440.00
1,618.00
18,411
EPS (Basic)
0.20
0.22
0.10
0.12
0.02
0.26
Basic Shares Outstanding
43,932.70
50,424.80
64,023.90
69,801.60
69,942.60
70,312.90
EPS (Diluted)
0.20
0.22
0.10
0.12
0.02
0.26
Diluted Shares Outstanding
43,932.70
50,424.80
64,023.90
69,801.60
69,942.60
70,312.90
EBITDA
8,695.00
11,795.00
9,587.00
11,596.00
13,958.00
20,166
Non-Operating Interest Income
70.00
139.00
340.00
1,544.00
-
39
About Silence Therapeutics
View Profile
